Young Kyun Chung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Young Kyun Chung has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Heon Keun Lee
Department of Anesthesiology and Pain Medicine, Gyeongsang National University College of Medicine, Jinju, Korea
17 shared publications- Il Woo Shin
Department of Anesthesiology and Pain Medicine, Gyeongsang National University Hospital, Jinju, Korea
14 shared publications - Ju Tae Sohn
Department of Anesthesiology and Pain Medicine, College of Medicine, Gyeongsang National University, Jinju, Korea
7 shared publications - Ju-Tae Sohn
Department of Anesthesiology and Pain Medicine, Gyeongsang National University College of Medicine, Gyeongsang National University Hospital, Jinju-si, Republic of Korea
4 shared publications In Seok Jang
Department of Thoracic Surgery, Gyeongsang National University College of Medicine, Jinju, Korea
3 shared publicationsJu Tae Shn
Departments of Anesthesia, Gyeongsang National University, Chinju, Korea
3 shared publications
Latest Publications
- Open Access
- 1 January 2011
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 61 (6) , 499-505
Myocardial protective effect by ulinastatin via an anti-inflammatory response after regional ischemia/reperfusion injury in an in vivo rat heart model
Ulinastatin has anti-inflammatory properties and protects organs from ischemia/reperfusion-induced injury. The aim of this study was to investigate whether ulinastatin provides a protective effect on a regional myocardial ischemia/reperfusion injury in an in vivo rat heart model and to determine whether the anti-inflammatory response is related to its myocardial protective effect. Rats were randomized to two groups. One group is received ulinastatin (50,000 U/kg or 100,000 U/kg) diluted in normal saline and the other group is received normal saline, which was administered intraperitoneally 30 min before the ischemic insult. Reperfusion after 30 min of ischemia of the left coronary artery territory was applied. Hemodynamic measurements were recorded serially during 6 h after reperfusion. After the 6 h reperfusion, myocardial infarct size, cardiac enzymes, myeloperoxidase activity, and inflammatory cytokine levels were compared between the ulinastatin treated and untreated groups. Ulinastatin improved cardiac function and reduced infarct size after regional ischemia/reperfusion injury. Ulinastatin significantly attenuated tumor necrosis factor-α expression and reduced myeloperoxidase activity. Ulinastatin showed a myocardial protective effect after regional ischemia/reperfusion injury in an in vivo rat heart model. This protective effect of ulinastatin might be related in part to ulinastatin's ability to inhibit myeloperoxidase activity and decrease expression of tumor necrosis factor-α.
- 1 January 2011
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 61 (6) , 499-505
Open AccessMyocardial protective effect by ulinastatin via an anti-inflammatory response after regional ischemia/reperfusion injury in an in vivo rat heart model
Ulinastatin has anti-inflammatory properties and protects organs from ischemia/reperfusion-induced injury. The aim of this study was to investigate whether ulinastatin provides a protective effect on a regional myocardial ischemia/reperfusion injury in an in vivo rat heart model and to determine whether the anti-inflammatory response is related to its myocardial protective effect. Rats were randomized to two groups. One group is received ulinastatin (50,000 U/kg or 100,000 U/kg) diluted in normal saline and the other group is received normal saline, which was administered intraperitoneally 30 min before the ischemic insult. Reperfusion after 30 min of ischemia of the left coronary artery territory was applied. Hemodynamic measurements were recorded serially during 6 h after reperfusion. After the 6 h reperfusion, myocardial infarct size, cardiac enzymes, myeloperoxidase activity, and inflammatory cytokine levels were compared between the ulinastatin treated and untreated groups. Ulinastatin improved cardiac function and reduced infarct size after regional ischemia/reperfusion injury. Ulinastatin significantly attenuated tumor necrosis factor-α expression and reduced myeloperoxidase activity. Ulinastatin showed a myocardial protective effect after regional ischemia/reperfusion injury in an in vivo rat heart model. This protective effect of ulinastatin might be related in part to ulinastatin's ability to inhibit myeloperoxidase activity and decrease expression of tumor necrosis factor-α.
- Open Access
- 1 January 2010
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 58 (4) , 378-382
Propofol has delayed myocardial protective effects after a regional ischemia/reperfusion injury in an in vivo rat heart model
It is well known that propofol protects myocardium against myocardial ischemia/reperfusion injury in the rat heart model. The aim of this study was to investigate whether propofol provides a protective effect against a regional myocardial ischemia/reperfusion injury in an in vivo rat heart model after 48 h of reperfusion. Rats were subjected to 25 min of left coronary artery occlusion followed by 48 h of reperfusion. The sham group received profopol without ischemic injury. The control group received normal saline with ischemia/reperfusion injury. The propofol group received profopol with ischemia/reperfusion injury. The intralipid group received intralipid with ischemia/reperfusion injury. A microcatheter was advanced into the left ventricle and the hemodynamic function was evaluated. The infarct size was determined by triphenyltetrazolium staining. The serum level of cardiac troponin-I (cTn-I) was determined by ELISA (enzyme-linked immunosorbent assay). Propofol demonstrated protective effects on hemodynamic function and infarct size reduction. In the propofol group, the +dP/dtmax (P = 0.002) was significantly improved compared to the control group. The infarct size was 49.8% of the area at risk in the control group, and was reduced markedly by administration of propofol to 32.6% in the propofol group (P = 0.014). The ischemia/reperfusion-induced serum level of cTn-I was reduced by propofol infusion during the peri-ischemic period (P = 0.0001). Propofol, which infused at clinically relevant concentration during the peri-ischemic period, has delayed myocardial protective effect after regional myocardial ischemia/reperfusion injury in an in vivo rat heart model after 48 h of reperfusion.
- 1 January 2010
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 58 (4) , 378-382
Open AccessPropofol has delayed myocardial protective effects after a regional ischemia/reperfusion injury in an in vivo rat heart model
It is well known that propofol protects myocardium against myocardial ischemia/reperfusion injury in the rat heart model. The aim of this study was to investigate whether propofol provides a protective effect against a regional myocardial ischemia/reperfusion injury in an in vivo rat heart model after 48 h of reperfusion. Rats were subjected to 25 min of left coronary artery occlusion followed by 48 h of reperfusion. The sham group received profopol without ischemic injury. The control group received normal saline with ischemia/reperfusion injury. The propofol group received profopol with ischemia/reperfusion injury. The intralipid group received intralipid with ischemia/reperfusion injury. A microcatheter was advanced into the left ventricle and the hemodynamic function was evaluated. The infarct size was determined by triphenyltetrazolium staining. The serum level of cardiac troponin-I (cTn-I) was determined by ELISA (enzyme-linked immunosorbent assay). Propofol demonstrated protective effects on hemodynamic function and infarct size reduction. In the propofol group, the +dP/dtmax (P = 0.002) was significantly improved compared to the control group. The infarct size was 49.8% of the area at risk in the control group, and was reduced markedly by administration of propofol to 32.6% in the propofol group (P = 0.014). The ischemia/reperfusion-induced serum level of cTn-I was reduced by propofol infusion during the peri-ischemic period (P = 0.0001). Propofol, which infused at clinically relevant concentration during the peri-ischemic period, has delayed myocardial protective effect after regional myocardial ischemia/reperfusion injury in an in vivo rat heart model after 48 h of reperfusion.
- Open Access
- 1 January 2009
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 57 (2) , 190-194
Dose remifentanil have a myocardial protective effect against a regional ischemia-reperfusion injury in an in vivo rat heart model?
Shin IW, et al. Korean J Anesthesiol. 2009 Aug;57(2):190-194. http://dx.doi.org/10.4097/kjae.2009.57.2.190
- 1 January 2009
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 57 (2) , 190-194
Open AccessDose remifentanil have a myocardial protective effect against a regional ischemia-reperfusion injury in an in vivo rat heart model?
Shin IW, et al. Korean J Anesthesiol. 2009 Aug;57(2):190-194. http://dx.doi.org/10.4097/kjae.2009.57.2.190
- Open Access
- 1 January 2008
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 55 (3) , 338-343
The effect of propofol on myocardial protection after regional ischemia-reperfusion injury in anin vivorat heart model
- 1 January 2008
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 55 (3) , 338-343
Open AccessThe effect of propofol on myocardial protection after regional ischemia-reperfusion injury in anin vivorat heart model
- Open Access
- 1 January 2005
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 49 (5) , 709
Weakness and Footdrop of Lower Extremity following Spinal Anesthesia: A case report
- 1 January 2005
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 49 (5) , 709
Open AccessWeakness and Footdrop of Lower Extremity following Spinal Anesthesia: A case report
- Open Access
- 1 January 2005
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 48 (5) , 489
Effect of Alfentail on Cardiovascular Response to Bronchoscopic Endotracheal Intubation
- 1 January 2005
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 48 (5) , 489
Open AccessEffect of Alfentail on Cardiovascular Response to Bronchoscopic Endotracheal Intubation
- Open Access
- 1 January 2005
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 48 (2) , 207
Femoro-femoral Cardiopulmonary Bypass during Tracheal Reconstruction Surgery: A case report
- 1 January 2005
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 48 (2) , 207
Open AccessFemoro-femoral Cardiopulmonary Bypass during Tracheal Reconstruction Surgery: A case report
- Open Access
- 1 January 2004
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 46 (1) , 23
The Effect of Spinal Anesthesia and Intrathecal Clonidine on the Propofol Hypnotic Requirements for Conscious Sedation
- 1 January 2004
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 46 (1) , 23
Open AccessThe Effect of Spinal Anesthesia and Intrathecal Clonidine on the Propofol Hypnotic Requirements for Conscious Sedation
- Open Access
- 1 January 2004
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 46 (4) , 489
Left Atrial Dissection by Aorto-Left Atrial Fistula after Aortic Valve Replacement: A case report
- 1 January 2004
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 46 (4) , 489
Open AccessLeft Atrial Dissection by Aorto-Left Atrial Fistula after Aortic Valve Replacement: A case report
- Open Access
- 1 January 2003
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 45 (4) , 528
Laryngeal Mask Airway as a Conduit for Fiberoptic Intubation and Tracheal Evaluation: 2 Cases report
- 1 January 2003
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 45 (4) , 528
Open AccessLaryngeal Mask Airway as a Conduit for Fiberoptic Intubation and Tracheal Evaluation: 2 Cases report